AUPH
NASDAQ · Biotechnology
Aurinia Pharmaceuticals Inc
$15.39
+0.25 (+1.65%)
Open$15.22
Previous Close$15.14
Day High$15.45
Day Low$15.14
52W High$16.88
52W Low$7.29
Volume—
Avg Volume1.23M
Market Cap2.02B
P/E Ratio7.02
EPS$2.08
SectorBiotechnology
Analyst Ratings
Buy
13 analysts
Price Target
+164.1% upside
Current
$15.39
$15.39
Target
$40.64
$40.64
$34.07
$40.64 avg
$61.77
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 267.49M | 208.47M | 554.79M |
| Net Income | 271.41M | 190.37M | -143,878,553 |
| Profit Margin | 101.5% | 96.4% | -25.9% |
| EBITDA | 117.52M | 87.01M | -183,212,536 |
| Free Cash Flow | — | — | -112,933,113 |
| Rev Growth | +28.3% | +28.3% | +6.7% |
| Debt/Equity | 0.12 | 0.12 | 0.45 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |